Development of an Adverse Outcome Pathway for Chemically Induced Hepatocellular Carcinoma: Case Study of AFB1, a Human Carcinogen With a Mutagenic Mode of Action

Critical Reviews in Toxicology - United Kingdom
doi 10.1080/10408444.2017.1423462
Full Text
Abstract

Available in full text

Categories
Toxicology
Date
Authors
Publisher

Informa UK Limited

Related search

ROS Induced Inflammation Is Key Driver of AFB1 Induced Hepatocellular Carcinoma

Journal of Liver Research, Disorders & Therapy
2018English

Adverse Outcome Pathway-Driven Analysis of Liver Steatosis in Vitro: A Case Study With Cyproconazole

English

A Case of Hepatocellular Carcinoma Presenting With Hemobilia

Nihon Kyukyu Igakukai Zasshi
2013English

Utility of the Adverse Outcome Pathway Concept in Drug Development

Expert Opinion on Drug Metabolism and Toxicology
MedicineToxicologyPharmacology
2016English

Selective Accumulation of ALA-induced PpIX and Photodynamic Effect in Chemically Induced Hepatocellular Carcinoma

British Journal of Cancer
Cancer ResearchOncology
2003English

Induction of Activation-Induced Cytidine Deaminase by a Not-Directly Mutagenic Carcinogen: A Novel Potential Molecular Mechanism

Environmental Health and Preventive Medicine
MedicineEnvironmentalPublic HealthOccupational Health
2014English

Application of the Adverse Outcome Pathway (AOP) Framework to Genotoxic Modes of Action (MOA)

Environmental and Molecular Mutagenesis
MutagenesisToxicologyHealthGeneticsEpidemiology
2019English

Updated Study on Action Mechanisms of Cereblon as a Novel Prognostic Biomarker for Hepatocellular Carcinoma

HPB
HepatologyGastroenterology
2019English

A Case-Control Study of Risk Factors for Hepatocellular Carcinoma in Henan, China.

American Journal of Tropical Medicine and Hygiene
MedicineVirologyParasitologyInfectious Diseases
1998English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy